高收入国家麻疹-腮腺炎-风疹疫苗非特异性效应的全国人群队列研究
荷兰全国疫苗登记与住院数据链接的基于人群队列,纳入2005—2011年出生、已接种前四剂DTaP-IPV-Hib+PCV的1 096 594名儿童。以最近接种疫苗为时变变量行Cox回归并校正混杂。以MMR+MenC为最近接种者因感染住院的HR为0.62(95%CI 0.57~0.67),因损伤或中毒住院的HR为0.84(95%CI 0.73~0.96);以第四剂DTaP-IPV-Hib+PCV为最近接种者因感染住院的HR为0.69(95%CI 0.63~0.76),对照为以第三剂为最近接种。作者结论认为健康接种者偏倚至少可部分解释观察到的较低住院率,且该较低率与接种任何额外疫苗相关,而非特异地与MMR疫苗相关。
要点
- 以MMR+MenC为最近接种的≤2岁儿童因感染住院风险低于以第四剂DTaP-IPV-Hib+PCV为最近接种者,HR 0.62(95%CI 0.57~0.67)。
- 同一比较中阴性对照结局(损伤或中毒住院)也降低,HR 0.84(95%CI 0.73~0.96),提示存在健康接种者偏倚。
- 以第四剂DTaP-IPV-Hib+PCV为最近接种者因感染住院风险低于以第三剂为最近接种者,HR 0.69(95%CI 0.63~0.76)。
- 作者结论:感染住院率降低与接种任何额外疫苗相关,并非MMR疫苗特异性效应。
- 作者强调解读观察性疫苗非特异性效应研究时需谨慎。
适用人群与场景
- 荷兰2005—2011年出生、已接种前四剂DTaP-IPV-Hib+PCV的儿童,共1 096 594名,分析年龄≤2岁。
- 全国疫苗登记数据与医院住院数据链接。
研究设计与关键结果
- 研究设计:全国基于人群队列研究;数据来源为荷兰全国疫苗登记与住院登记链接。
- 主要终点:以MMR+MenC为最近接种者因感染住院的HR为0.62(95%CI 0.57~0.67),对照为以第四剂DTaP-IPV-Hib+PCV为最近接种。
- 阴性对照结局:同一比较中因损伤或中毒住院的HR为0.84(95%CI 0.73~0.96)。
- 关键次要分析:以第四剂DTaP-IPV-Hib+PCV为最近接种者因感染住院的HR为0.69(95%CI 0.63~0.76),对照为以第三剂为最近接种。
- 统计方法:Cox回归,以最近接种疫苗为时变变量,校正潜在混杂因素。
证据类型、等级与局限
- 证据类型:全国基于人群队列研究。
- 作者结论:健康接种者偏倚至少可部分解释MMR接种后观察到的较低感染住院率;该较低率与接种任何额外疫苗相关,而非特异地与MMR疫苗相关。
- 作者指出:解读观察性疫苗非特异性效应研究结果时需谨慎。
对床旁实践的改变
- 作者结论提示:观察性研究中MMR接种后感染住院率降低不能直接归因于MMR的非特异性保护效应,需考虑健康接种者偏倚。
- 作者结论提示:感染住院率降低与接种任何额外疫苗相关,解读疫苗非特异性效应研究时应谨慎。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
Objectives To investigate whether measles, mumps, and rubella (MMR) vaccine has positive non-specific effects in a high income setting and to compare rates of hospital admissions for infections between children aged ≤2 years who received live MMR vaccine and those who received an inactivated vaccine against diphtheria, tetanus, pertussis, polio, and Haemophilus influenzae type b (DTaP-IPV-Hib) as their most recent vaccination.Design Nationwide population based cohort study.Setting In the Netherlands, DTaP-IPV-Hib+pneumococcal vaccination (PCV) is recommended at ages 2, 3, 4, and 11 months and MMR + meningococcal C (MenC) vaccination at age 14 months. Data from the national vaccine register were linked to hospital admission data.Participants 1 096 594 children born in 2005-11 who received the first four DTaP-IPV-Hib+PCV vaccines.Main outcome measures Hazard ratio for admission to hospital for infection in children with MMR+MenC compared with the fourth DTaP-IPV-Hib+PCV as their most recent vaccination. Cox regression was performed with most recent vaccination as time dependent variable, adjusted for potential confounders. Analyses were repeated with admission for injuries or poisoning as a negative control outcome. In addition, rate of admission for infection was compared between the fourth and third DTaP-IPV-Hib+PCVas most recent vaccination.Results Having had MMR+MenC as the most recent vaccination was associated with a hazard ratio of 0.62 (95% confidence interval 0.57 to 0.67) for admission to hospital for infection and 0.84 (0.73 to 0.96) for injuries or poisoning, compared with the fourth DTaP-IPV-Hib+PCV as most recent vaccination. The fourth DTaP-IPV-Hib+PCV as most recent vaccination was associated with a hazard ratio of 0.69 (0.63 to 0.76) for admission to hospital for infection, compared with the third DTaP-IPV-Hib+PCV as most recent vaccination.Conclusions Healthy vaccinee bias could at least partly explain the observed lower rate of admission to hospital with infection after MMR vaccination. The lower rate is associated with receipt of any additional vaccine, not specifically MMR vaccine. This emphasises the caution required in the interpretation of findings from observational studies on non-specific effects of vaccination.
参考来源
- Tielemans SMAJ, de Melker HE, Hahné SJM, et al. Non-specific effects of measles, mumps, and rubella (MMR) vaccination in high income setting: population based cohort study in the Netherlands. BMJ. 2017. PMID: 28855159. doi:10.1136/bmj.j3862
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。